amikacin has been researched along with Renal Insufficiency in 11 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (9.09) | 18.2507 |
2000's | 2 (18.18) | 29.6817 |
2010's | 5 (45.45) | 24.3611 |
2020's | 3 (27.27) | 2.80 |
Authors | Studies |
---|---|
Khattab, MI; Khorshid, NE; Saeed, ZM; Salem, AE | 1 |
Endo, A; Hanawa, K; Hanawa, T; Ishikawa, T; Kagami, Y; Katsumata, N; Kawano, Y; Kazama, S; Kobayashi, Y; Maebayashi, Y; Naito, A; Nemoto, A | 1 |
Budhathoki, C; Dooley, KE; Dowdy, DW; Farley, JE; Francis, HW; Han, HR; Hong, H | 1 |
Antonopoulos, IM; David-Neto, E; de Paula, FJ; Freire, MP; Guimarães, T; Moura, ML; Nahas, WC; Pierrotti, LC; Piovesan, AC; Spadão, F | 1 |
Asci, H; Bayram, D; Candan, IA; Cankara, FN; Ilhan, I; Saygin, M; Yesilot, S | 1 |
Koch, G; Pfister, M; Schropp, J | 1 |
Abdel-Hady, E; Awad, H; El Hamamsy, M; Hedaya, M | 1 |
Allegaert, K; Danhof, M; De Cock, RF; de Hoog, M; Knibbe, CA; Schreuder, MF; Sherwin, CM; van den Anker, JN | 1 |
Bladé, J; Bosch, F; Montagut, C; Rosiñol, L; Villela, L | 1 |
Ersoz, S; Gul, S; Kaynar, K; Ozdemir, F; Ulusoy, H; Ulusoy, S | 1 |
Fujita, H; Ikeda, Y; Ishii, M; Kihara, M; Masumori, S; Shibata, K; Shionoiri, H; Shiratori, K; Takagi, N; Umemura, S | 1 |
1 trial(s) available for amikacin and Renal Insufficiency
Article | Year |
---|---|
The efficacy and toxicity of two dosing-regimens of amikacin in neonates with sepsis.
Topics: Acetylglucosaminidase; Amikacin; Anti-Bacterial Agents; Creatinine; Drug Administration Schedule; Female; Half-Life; Humans; Infant, Newborn; Male; Metabolic Clearance Rate; Renal Insufficiency; Sepsis | 2011 |
10 other study(ies) available for amikacin and Renal Insufficiency
Article | Year |
---|---|
Ellagic acid and cilostazol ameliorate amikacin-induced nephrotoxicity in rats by downregulating oxidative stress, inflammation, and apoptosis.
Topics: Amikacin; Animals; Antioxidants; Apoptosis; bcl-2-Associated X Protein; Cilostazol; Ellagic Acid; Inflammation; Kidney; Lipid Peroxidation; Oxidative Stress; Rats; Renal Insufficiency | 2022 |
Evaluation of nephrotoxicity and ototoxicity following amikacin administration once daily or every 48 hours in neonates.
Topics: Amikacin; Anti-Bacterial Agents; Humans; Infant, Newborn; Kidney; Ototoxicity; Renal Insufficiency | 2022 |
Prevalence of Pre-Existing Hearing Loss Among Patients With Drug-Resistant Tuberculosis in South Africa.
Topics: Adolescent; Adult; Amikacin; Aminoglycosides; Anti-Bacterial Agents; Antitubercular Agents; Audiometry; Auditory Threshold; Cross-Sectional Studies; Female; Hearing Loss; HIV Infections; Humans; Hypoalbuminemia; Kanamycin; Male; Middle Aged; Ototoxicity; Prevalence; Renal Insufficiency; South Africa; Thinness; Tuberculosis, Multidrug-Resistant; Young Adult | 2020 |
Amikacin prophylaxis and risk factors for surgical site infection after kidney transplantation.
Topics: Adolescent; Adult; Aged; Amikacin; Anti-Bacterial Agents; Antibiotic Prophylaxis; Antilymphocyte Serum; beta-Lactamases; Cephalosporins; Child; Cohort Studies; Delayed Graft Function; Enterobacteriaceae Infections; Female; Graft Survival; Humans; Incidence; Kidney Transplantation; Male; Middle Aged; Multivariate Analysis; Renal Insufficiency; Risk Factors; Surgical Wound Infection; Time Factors; Tissue Donors; Treatment Outcome; Young Adult | 2015 |
The impact of alpha-lipoic acid on amikacin-induced nephrotoxicity.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Antioxidants; Blood Urea Nitrogen; Creatinine; Disease Models, Animal; Drug-Related Side Effects and Adverse Reactions; Female; Kidney; Kidney Function Tests; Malondialdehyde; Rats; Rats, Wistar; Renal Insufficiency; Thioctic Acid; Treatment Outcome | 2015 |
Facilitate Treatment Adjustment After Overdosing: Another Step Toward 21st-Century Medicine.
Topics: Amikacin; Anti-Bacterial Agents; Drug Overdose; Humans; Infant; Infant, Newborn; Kidney; Male; Medication Errors; Models, Biological; Pharmaceutical Preparations; Renal Insufficiency; Vancomycin | 2017 |
Maturation of the glomerular filtration rate in neonates, as reflected by amikacin clearance.
Topics: Age Factors; Amikacin; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Birth Weight; Child Development; Computer Simulation; Drug Interactions; Glomerular Filtration Rate; Humans; Ibuprofen; Infant, Newborn; Infant, Premature; Kidney Glomerulus; Metabolic Clearance Rate; Models, Biological; Premature Birth; Renal Insufficiency; Severity of Illness Index | 2012 |
Aminoglycoside-associated severe renal failure in patients with multiple myeloma treated with thalidomide.
Topics: Aged; Amikacin; Anti-Bacterial Agents; Fatal Outcome; Female; Humans; Male; Middle Aged; Multiple Myeloma; Renal Insufficiency; Salvage Therapy; Thalidomide | 2004 |
Amikacin-induced nephropathy: is there any protective way?
Topics: Acetylcysteine; Amikacin; Animals; Anti-Bacterial Agents; Creatinine; Free Radical Scavengers; Kidney Tubules; Mice; Mice, Inbred BALB C; Renal Insufficiency | 2007 |
Pharmacokinetics of single-dose intravenous amikacin in critically ill patients undergoing slow hemodialysis.
Topics: Aged; Amikacin; Critical Care; Drug Administration Schedule; Female; Half-Life; Humans; Injections, Intravenous; Male; Metabolic Clearance Rate; Renal Dialysis; Renal Insufficiency; Time Factors | 1995 |